Notice of Change to Application Types Allowed in PA-17-239 "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)"

Notice Number: NOT-CA-18-080

Key Dates
Release Date:   June 25, 2018

Related Announcements
PA-17-239

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to revise Application Types Allowed in PA-17-239 "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)".

 The following sections of PA-17-239 have been revised:

Part 2. Full Text of Announcement

Section II. Award Information

Currently reads:

Application Types Allowed  

New

Resubmission

Modified to Read (in italics):

Application Types Allowed  

New

Resubmission

Renewal

Section V. Application Review Information

1. Criteria

Currently reads:

Renewals

Not Applicable

Modified to Read (in italics):

Renewals

For Renewals, the committee will consider the progress made in the last funding period.

All other aspects of this Funding Opportunity Announcement remain unchanged.

Inquiries

Please direct all inquiries to:

Melissa Rotunno, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7245 
Email: rotunnom@mail.nih.gov